Pfizer Stock's Post-Covid Yav Tom Ntej Zoo Zoo

Cov ntawv ceeb toom no, sau tawm thiab kho los ntawm Barron's, tau tshaj tawm tsis ntev los no los ntawm kev nqis peev thiab tshawb nrhiav cov tuam txhab. Cov ntawv tshaj tawm yog ib qho piv txwv ntawm cov kws tshuaj ntsuam txoj kev xav; lawv yuav tsum tsis txhob suav hais tias yog cov kev pom lossis kev pom zoo ntawm Barron li. Qee cov ntaub ntawv xa tawm tau muab, lossis vam tias yuav muab, peev-tuam txhab nyiaj lossis lwm yam kev pabcuam rau cov tuam txhab tau txheeb xyuas.



Pfizer


PFE-NYSE

Yuav • Nqe $46.55 0n Kaum Hli 31

los ntawm BofA Kev Pov Hwm

Pfizer shares yog trading siab dua hnub no [Nov. 1]. tom qab nws tau tshaj tawm cov txiaj ntsig zoo ntawm peb lub hlis twg los ntawm cov nyiaj tau los ntau dua ($ 1.5 billion) thiab cov nyiaj tau los tsis yog GAAP ib feem (38 xees).

Tau qhov twg los: https://www.barrons.com/articles/pfizer-stocks-post-covid-future-looks-healthy-51667601302?siteid=yhoof2&yptr=yahoo